Stockreport

Exelixis Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Exelixis, Inc.  (EXEL) 
Last exelixis, inc. earnings: 2/25 04:05 pm Check Earnings Report
PDF - Total Revenues of $597.8 million, Cabozantinib Franchise U.S. Net Product Revenues of $542.9 million -- GAAP Diluted EPS of $0.69, Non-GAAP Diluted EPS of $0.78 -- Ann [Read more]